While different ovarian cancer cell lines were utilized in the studies, interleukin-6 (IL-6) was examined to varying degrees in all three studies, likely due to its known roles in ovarian cancer progression (Dijkgraaf et al., 2012) and its association with the induction of cachexia (Bonetto et al., 2012). The gene discussed is IL6; the disease is ovarian carcinoma.